Source:Columbia University Medical Center
Summary:Researchers have discovered a molecular mechanism that reprograms tumor cells in patients with advanced prostate cancer, reducing their response to anti-androgen therapy. The findings, based on a study in mice, could help to determine which patients should avoid anti-androgen therapy and identify new treatments for people with advanced prostate cancer.
https://www.sciencedaily.com/releases/2017/05/170504161518.htm